Treatment outcomes by histology in REVEL: A randomized phase III trial of Ramucirumab plus docetaxel for advanced non-small cell lung cancer
| Title: | Treatment outcomes by histology in REVEL: A randomized phase III trial of Ramucirumab plus docetaxel for advanced non-small cell lung cancer |
|---|---|
| Authors: | Paz-Ares, Luis G., Pérol, Maurice, Ciuleanu, Tudor-Eliade, Kowalyszyn, Ruben Dario, Reck, Martin, Lewanski, Conrad R., Syrigos, Konstantinos, Arrieta, Oscar, Prabhash, Kumar, Park, Keunchil, Pikiel, Joanna, Göksel, Tuncay, Lee, Pablo, Zimmermann, Anna, Carter, Gebra Cuyun, Alexandris, Ekaterine, Garon, Edward B. |
| Source: | In Lung Cancer October 2017 112:126-133 |
| Database: | ScienceDirect |
Be the first to leave a comment!